Telomere dysfunction impairs intestinal differentiation and predisposes to diet-induced colitis
暂无分享,去创建一个
J. A. Halliday | E. Sahin | N. Oezguen | C. Coarfa | S. Colla | J. Baur | N. Putluri | Jianhua Gu | A. Catic | A. Engevik | Lei Guo | Cholsoon Jang | R. Ferraris | N. Shroyer | C. Herman | H. Dierick | M. Finegold | Won-Suk Song | Mindy Engevik | Christopher G Chronowski | Viktor Akhanov | Navish Bosquez | Jianhua Gu | Mindy A. Engevik | Ergun Sahin
[1] E. Untersmayr,et al. The Intestinal Barrier Dysfunction as Driving Factor of Inflammaging , 2022, Nutrients.
[2] M. Gonzalez‐Freire,et al. Organoids: An Emerging Tool to Study Aging Signature across Human Tissues. Modeling Aging with Patient-Derived Organoids , 2021, International journal of molecular sciences.
[3] R. DePinho,et al. Telomere dysfunction instigates inflammation in inflammatory bowel disease , 2021, Proceedings of the National Academy of Sciences.
[4] H. Clevers,et al. Cell fate specification and differentiation in the adult mammalian intestine , 2020, Nature reviews. Molecular cell biology.
[5] R. DePinho,et al. Telomere dysfunction activates YAP1 to drive tissue inflammation , 2020, Nature Communications.
[6] Martin T. Wells,et al. Dietary Fructose Alters the Composition, Localization, and Metabolism of Gut Microbiota in Association With Worsening Colitis , 2020, Cellular and molecular gastroenterology and hepatology.
[7] C. Feighery,et al. Coeliac Disease Pathogenesis: The Uncertainties of a Well-Known Immune Mediated Disorder , 2020, Frontiers in Immunology.
[8] J. Rabinowitz,et al. The small intestine shields the liver from fructose-induced steatosis , 2020, Nature Metabolism.
[9] M. Boutros,et al. Ageing, metabolism and the intestine , 2020, EMBO reports.
[10] W. Fok,et al. Telomere Dysfunction Activates p53 and Represses HNF4α Expression Leading to Impaired Human Hepatocyte Development and Function , 2020, Hepatology.
[11] M. Lanaspa,et al. Deletion of Fructokinase in the Liver or in the Intestine Reveals Differential Effects on Sugar-Induced Metabolic Dysfunction. , 2020, Cell metabolism.
[12] J. Rabinowitz,et al. Dietary fructose feeds hepatic lipogenesis via microbiota-derived acetate , 2020, Nature.
[13] Alex Coutts,et al. Editing Myosin VB Gene to Create Porcine Model of Microvillus Inclusion Disease, With Microvillus-lined Inclusions and Alterations in Sodium Transporters. , 2020, Gastroenterology.
[14] M. Ribolsi,et al. Nutritional Aspects in Inflammatory Bowel Diseases , 2020, Nutrients.
[15] I. Cózar-Castellano,et al. Intestinal Fructose and Glucose Metabolism in Health and Disease , 2019, Nutrients.
[16] Alejandro Lucia,et al. Chronic inflammation in the etiology of disease across the life span , 2019, Nature Medicine.
[17] Jeffrey T. Chang,et al. Telomere Dysfunction Induces Sirtuin Repression that Drives Telomere-Dependent Disease. , 2019, Cell metabolism.
[18] L. Cantley,et al. High-fructose corn syrup enhances intestinal tumor growth in mice , 2019, Science.
[19] M. Terris,et al. Serum Metabolic Profiling Identified a Distinct Metabolic Signature in Bladder Cancer Smokers: A Key Metabolic Enzyme Associated with Patient Survival , 2019, Cancer Epidemiology, Biomarkers & Prevention.
[20] Elizabeth A. Kennedy,et al. Mouse Microbiota Models: Comparing Germ-Free Mice and Antibiotics Treatment as Tools for Modifying Gut Bacteria , 2018, Front. Physiol..
[21] Patrick K. Kimes,et al. Abnormal Small Intestinal Epithelial Microvilli in Patients With Crohn's Disease. , 2018, Gastroenterology.
[22] Q. Feng,et al. TFAM is required for maturation of the fetal and adult intestinal epithelium. , 2018, Developmental biology.
[23] J. Rabinowitz,et al. Metabolomics and Isotope Tracing , 2018, Cell.
[24] D. Gibson,et al. Age and Age-Related Diseases: Role of Inflammation Triggers and Cytokines , 2018, Front. Immunol..
[25] M. Herman,et al. Fructose metabolism and metabolic disease , 2018, The Journal of clinical investigation.
[26] H. Tilg,et al. NAD metabolism fuels human and mouse intestinal inflammation , 2017, Gut.
[27] Michael J. Barratt,et al. The Gut Microbiota, Food Science, and Human Nutrition: A Timely Marriage. , 2017, Cell host & microbe.
[28] E. Vilar,et al. SPDEF Induces Quiescence of Colorectal Cancer Cells by Changing the Transcriptional Targets of β-catenin. , 2017, Gastroenterology.
[29] S. Bischoff,et al. Intestinal Barrier Function and the Gut Microbiome Are Differentially Affected in Mice Fed a Western-Style Diet or Drinking Water Supplemented with Fructose. , 2017, The Journal of nutrition.
[30] Amy D. Hanna,et al. A chemical chaperone improves muscle function in mice with a RyR1 mutation , 2017, Nature Communications.
[31] John P. Lynch,et al. Mutual reinforcement between telomere capping and canonical Wnt signalling in the intestinal stem cell niche , 2017, Nature Communications.
[32] J. Turner,et al. The intestinal epithelial barrier: a therapeutic target? , 2017, Nature Reviews Gastroenterology &Hepatology.
[33] Patrice D Cani,et al. Human Intestinal Barrier Function in Health and Disease , 2016, Clinical and Translational Gastroenterology.
[34] C. Lengner,et al. Enhancing a Wnt-Telomere Feedback Loop Restores Intestinal Stem Cell Function in a Human Organotypic Model of Dyskeratosis Congenita. , 2016, Cell stem cell.
[35] Fabiano Pinheiro da Silva,et al. Intestinal Barrier Dysfunction in Human Pathology and Aging. , 2016, Current pharmaceutical design.
[36] Jichun Chen,et al. Hematopoietic lineage skewing and intestinal epithelia degeneration in aged mice with telomerase RNA component deletion , 2015, Experimental Gerontology.
[37] T. Brümmendorf,et al. Telomere shortening in enterocytes of patients with uncontrolled acute intestinal graft-versus-host disease. , 2015, Blood.
[38] A. Bretscher,et al. Structure, regulation, and functional diversity of microvilli on the apical domain of epithelial cells. , 2015, Annual review of cell and developmental biology.
[39] I. Bergheim,et al. Diets rich in fructose, fat or fructose and fat alter intestinal barrier function and lead to the development of nonalcoholic fatty liver disease over time. , 2015, The Journal of nutritional biochemistry.
[40] L. Cigliano,et al. Rescue of Fructose-Induced Metabolic Syndrome by Antibiotics or Faecal Transplantation in a Rat Model of Obesity , 2015, PloS one.
[41] D. French,et al. Impaired Telomere Maintenance and Decreased Canonical WNT Signaling but Normal Ribosome Biogenesis in Induced Pluripotent Stem Cells from X-Linked Dyskeratosis Congenita Patients , 2015, PloS one.
[42] H. Kestler,et al. Wnt activity and basal niche position sensitize intestinal stem and progenitor cells to DNA damage , 2015, The EMBO journal.
[43] Matthew E. Ritchie,et al. limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.
[44] M. Tyska,et al. Shaping the intestinal brush border , 2014, The Journal of cell biology.
[45] T. Illig,et al. Glucose substitution prolongs maintenance of energy homeostasis and lifespan of telomere dysfunctional mice , 2014, Nature Communications.
[46] C. Loddenkemper,et al. A guide to histomorphological evaluation of intestinal inflammation in mouse models. , 2014, International journal of clinical and experimental pathology.
[47] J. Turner,et al. Recipient NK cell inactivation and intestinal barrier loss are required for MHC-matched graft-versus-host disease , 2014, Science Translational Medicine.
[48] H. Clevers,et al. Loss of syntaxin 3 causes variant microvillus inclusion disease. , 2014, Gastroenterology.
[49] F. D. de Sauvage,et al. Lgr5+ stem cells are indispensable for radiation-induced intestinal regeneration. , 2014, Cell stem cell.
[50] S. Savage. Human telomeres and telomere biology disorders. , 2014, Progress in molecular biology and translational science.
[51] J. Shay,et al. Cell biology of disease Telomeropathies : An emerging spectrum disorder , 2014 .
[52] Charity W. Law,et al. voom: precision weights unlock linear model analysis tools for RNA-seq read counts , 2014, Genome Biology.
[53] Toshiro Sato,et al. Establishment of Gastrointestinal Epithelial Organoids , 2013, Current protocols in mouse biology.
[54] E. Montgomery,et al. The gastrointestinal manifestations of telomere‐mediated disease , 2013, Aging cell.
[55] F. Bäckhed,et al. The gut microbiota — masters of host development and physiology , 2013, Nature Reviews Microbiology.
[56] M. Armanios. Telomeres and age-related disease: how telomere biology informs clinical paradigms. , 2013, The Journal of clinical investigation.
[57] J. Mclaughlin,et al. Ageing and the gut , 2012, Proceedings of the Nutrition Society.
[58] D. Sinderen,et al. Gut microbiota composition correlates with diet and health in the elderly , 2012, Nature.
[59] J. Burleson,et al. Inflammation associated with neoplastic colonic polyps. , 2012, Annals of clinical and laboratory science.
[60] J. Auwerx,et al. The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity. , 2012, Cell metabolism.
[61] R. Coffey,et al. Enterocyte Microvillus-Derived Vesicles Detoxify Bacterial Products and Regulate Epithelial-Microbial Interactions , 2012, Current Biology.
[62] D. Bonthron,et al. Opposing effects of fructokinase C and A isoforms on fructose-induced metabolic syndrome in mice , 2012, Proceedings of the National Academy of Sciences.
[63] M. Speicher,et al. Puma and p21 represent cooperating checkpoints limiting self-renewal and chromosomal instability of somatic stem cells in response to telomere dysfunction , 2011, Nature Cell Biology.
[64] N. Shroyer,et al. Intestinal development and differentiation. , 2011, Experimental cell research.
[65] Helga Thorvaldsdóttir,et al. Molecular signatures database (MSigDB) 3.0 , 2011, Bioinform..
[66] L. Chin,et al. Telomere dysfunction induces metabolic and mitochondrial compromise , 2011, Nature.
[67] S. Savage,et al. The genetics and clinical manifestations of telomere biology disorders , 2010, Genetics in Medicine.
[68] H. Clevers,et al. Stem cells and cancer of the stomach and intestine , 2010, Molecular oncology.
[69] David S. Wishart,et al. MSEA: a web-based tool to identify biologically meaningful patterns in quantitative metabolomic data , 2010, Nucleic Acids Res..
[70] Ronald A. DePinho,et al. Linking functional decline of telomeres, mitochondria and stem cells during ageing , 2010, Nature.
[71] A. Marchiando,et al. Epithelial barriers in homeostasis and disease. , 2010, Annual review of pathology.
[72] Charles Brenner,et al. Microbial NAD Metabolism: Lessons from Comparative Genomics , 2009, Microbiology and Molecular Biology Reviews.
[73] H. Clevers,et al. Single Lgr5 stem cells build cryptvillus structures in vitro without a mesenchymal niche , 2009, Nature.
[74] K. Kaestner,et al. Establishment of intestinal identity and epithelial-mesenchymal signaling by Cdx2. , 2009, Developmental cell.
[75] B. Giepmans,et al. Epithelial cell-cell junctions and plasma membrane domains. , 2009, Biochimica et biophysica acta.
[76] Hans Clevers,et al. Crypt stem cells as the cells-of-origin of intestinal cancer , 2009, Nature.
[77] John S. White,et al. Straight talk about high-fructose corn syrup: what it is and what it ain't. , 2008, The American journal of clinical nutrition.
[78] L. Huber,et al. MYO5B mutations cause microvillus inclusion disease and disrupt epithelial cell polarity , 2008, Nature Genetics.
[79] Jasmine L. Gallaher,et al. Ulcerative colitis is a disease of accelerated colon aging: evidence from telomere attrition and DNA damage. , 2008, Gastroenterology.
[80] C. McClain,et al. Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin. , 2008, Journal of hepatology.
[81] Jian Zuo,et al. THE Slc 2 a 5 ( Glut 5 ) IS ESSENTIAL FOR THE ABSORPTION OF FRUCTOSE IN THE INTESTINE AND GENERATION OF FRUCTOSE-INDUCED HYPERTENSION , 2008 .
[82] H. Clevers,et al. Identification of stem cells in small intestine and colon by marker gene Lgr5 , 2007, Nature.
[83] E. Mardis,et al. An obesity-associated gut microbiome with increased capacity for energy harvest , 2006, Nature.
[84] Hong Jiang,et al. Cdkn1a deletion improves stem cell function and lifespan of mice with dysfunctional telomeres without accelerating cancer formation , 2006, Nature Genetics.
[85] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[86] K. Kaukinen,et al. Inflammatory processes have differential effects on claudins 2, 3 and 4 in colonic epithelial cells , 2005, Laboratory Investigation.
[87] E. Cox,et al. The role of enterocytes in the intestinal barrier function and antigen uptake. , 2005, Microbes and infection.
[88] M. Selsted,et al. Mammalian defensins in the antimicrobial immune response , 2005, Nature Immunology.
[89] Ruslan Medzhitov,et al. Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis , 2004, Cell.
[90] M. Viola,et al. Telomere length study in celiac disease , 2003, American Journal of Gastroenterology.
[91] A. Namane,et al. Alterations of the intestinal transport and processing of gliadin peptides in celiac disease. , 2003, Gastroenterology.
[92] J. Potter,et al. Chromosomal instability in ulcerative colitis is related to telomere shortening , 2002, Nature Genetics.
[93] T. Vulliamy,et al. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita , 2001, Nature.
[94] I. Arnott,et al. Abnormal Intestinal Permeability Predicts Relapse in Inactive Crohn Disease , 2000, Scandinavian journal of gastroenterology.
[95] Lynda Chin,et al. p53 Deficiency Rescues the Adverse Effects of Telomere Loss and Cooperates with Telomere Dysfunction to Accelerate Carcinogenesis , 1999, Cell.
[96] J. Schulzke,et al. Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis. , 1999, Gastroenterology.
[97] J. Shay,et al. Telomerase activity in human intestine. , 1996, International journal of oncology.
[98] H. Lochs,et al. Intestinal permeability and the prediction of relapse in Crohri's disease , 1993, The Lancet.
[99] G. May,et al. Is small intestinal permeability really increased in relatives of patients with Crohn's disease? , 1993, Gastroenterology.
[100] Robin C. Allshire,et al. Telomere reduction in human colorectal carcinoma and with ageing , 1990, Nature.
[101] D. Hollander,et al. Crohn's disease--a permeability disorder of the tight junction? , 1988, Gut.
[102] J. Rotter,et al. Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor. , 1986, Annals of internal medicine.
[103] S. Ukabam,et al. Abnormal small intestinal permeability to sugars in patients with Crohn's disease of the terminal ileum and colon. , 1983, Digestion.
[104] A. Craft,et al. Intestinal permeability in children with Crohn's disease and coeliac disease. , 1982, British medical journal.
[105] H. Withers,et al. Microcolony survival assay for cells of mouse intestinal mucosa exposed to radiation. , 1970, International journal of radiation biology and related studies in physics, chemistry, and medicine.